Why Lattice Semiconductor Shares Are Diving Premarket Today

Lattice appointed Esam Elashmawi, chief marketing and strategy officer, as Interim Chief Executive Officer, effective immediately.

Lattice Semiconductor Corporation (NASDAQ:LSCC) shares are trading lower after the company announced that Jim Anderson decided to step down as president, CEO, and board member.

The company announced the appointment of Esam Elashmawi, chief marketing and strategy officer, as Interim Chief Executive Officer, effective immediately.

The board started a search process to identify a permanent CEO and will consider internal and external candidates as part of its search.

Jeff Richardson, chair of Lattice’s board said, “Over the last six years, Esam has played a critical role in Lattice’s transformation. I am confident that Esam and our talented executive team will ensure a smooth transition for all our stakeholders.”

“With clear strategic priorities in place, and significant opportunity for growth and value creation, the Board is confident the Company is well positioned to build upon its track record of delivering outstanding results.”

In April, Lattice Semiconductor reported a 17% Y/Y revenue decline in the first quarter. 

Investors can gain exposure to the stock via Themes Generative Artificial Intelligence ETF (NASDAQ:WISE) and Global X Internet Of Things ETF (NASDAQ:SNSR).

Price Action: LSCC shares are down 14.40% at $63.66 at the last check Monday.

Now Read: These Analysts Boost Their Forecasts On Lattice Semiconductor Following Q1 Earnings

Total
0
Shares
Related Posts
Read More

ALX Oncology Announced First Patient Dosed in ASPEN-07, a Phase 1 Study of Evorpacept for the Treatment of Patients with Urothelial Cancer

ALX Oncology Holdings Inc., ("ALX Oncology") (NASDAQ: ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced the first patient has been dosed in the ASPEN-07 study evaluating evorpacept, a next generation CD47 blocker, in combination with PADCEV® (enfor

ALXO